secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001459839-21-000051
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE posts record Q2 revenue of $22.2M, gets exclusive Anthem coverage
-------------------------------------------------------------------------

- Record Q2 worldwide revenue $22.2M (+58% YoY); U.S. revenue $20.2M (+53%).
- Exclusive coverage from Anthem (40M+ members) expands SI joint fusion access; also positive Centene coverage.
- Gross margin 89%; guidance raised to 87-89%; FY2021 revenue guidance maintained $92-94M.
- Net loss $14.0M ($0.42/sh) vs $12.5M ($0.44/sh) prior year; operating loss $13.0M.
- Published 2-year clinical trial results for iFuse-3D Implant System, 95th peer-reviewed publication.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/0001459839-21-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/sibn-20210802.htm
  HTML page:      https://secwatch.observer/filing/0001459839-21-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer